This combination peptide pairs CJC-1295, a growth hormone–releasing hormone (GHRH) analog, with Ipamorelin, a growth hormone secretagogue. It is studied for synergistic stimulation of endogenous growth hormone release and enhanced anabolic signaling. In experimental studies, this combination has been investigated for its effects on metabolism, tissue repair, and muscle growth. It is commonly considered in preclinical models exploring growth hormone regulation, body composition improvement, and regenerative pathways. Studied for synergistic stimulation of endogenous growth hormone Investigated for effects on metabolism, tissue repair, and recovery Explored for potential anabolic and body composition benefits Considered in preclinical models of growth, regenerative, and endocrine research
